Vivani Medical, Inc. Cash Flow Statement
VANI|3 years of annual SEC 10-K data (FY2015-FY2017)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 3 fiscal years. All figures from audited SEC 10-K filings.
Vivani Medical, Inc. used $21M in operating cash flow and negative free cash flow of $21M in FY2017.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -4.83 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2017 | FY2016 | FY2015 |
|---|---|---|---|
| Net Income | -$20.0M | -$35.2M | -$23.0M |
| Depreciation & Amortization | $335.0K | $279.0K | $316.0K |
| Operating Cash Flow | -$20.5M | -$17.1M | -$17.4M |
| Capital Expenditures | $762.0K | $560.0K | $246.0K |
| Free Cash Flow | -$21.3M | -$17.7M | -$17.7M |
| FCF Margin | -238.1% | -519.2% | -1129.3% |